Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis

Published:2024-01 Issue:2 Volume:10 Page:e24395
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Tang Donghao^ORCID,Feng Yuejiao,Lu Jiahao,Jia Linlin,Shen Dongxiao,Shang Jing,Chen Teng,Yin Peihao,Chen Jinbao,Wang Jie

Publisher

Elsevier BV

Reference54 articles.

1. Cancer statistics, 2023;Siegel;CA. Cancer J. Clin.,2023

2. Nanoparticles in the diagnosis and treatment of cancer metastases: current and future perspectives;Hegde;Cancer Lett.,2023

3. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies;Ho;Crit. Rev. Oncol. Hematol.,2016

4. Efficacy and safety of treatments for advanced thymic carcinoma after failure of first-line platinum-based chemotherapy: a systematic literature review and meta-analysis;Arunachalam;Lung Cancer Amst. Neth,2023

5. Natural products to prevent drug resistance in cancer chemotherapy: a review;Yuan;Ann. N. Y. Acad. Sci.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP